ALPRE.PA
Predilife S.A. [ALPRE.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALPRE.PA Stock Summary
Top 10 Correlated ETFs
ALPRE.PA
Top 10 Correlated Stocks
ALPRE.PA
In the News
ALPRE.PA Financial details
Company Rating
-
Market Cap
16.68M
Income
-7.15M
Revenue
556.29K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
28 Oct 2023
P/E
-5.91
Forward P/E
-
PEG
-0.54
P/S
73.81
P/B
-4.03
P/C
-
P/FCF
-6.89
Quick Ratio
2.96
Current Ratio
3.57
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.96
EPS next Y
-
EPS next Q
-
EPS this Y
6.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.06%
Revenue last 5Y
31.91%
Revenue Q/Q
20.2%
EPS Q/Q
-3.64%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-75%
ROE
105%
ROC
-1.01%
Gross Margin
87%
Oper. Margin
-1212%
Profit Margin
-1232%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.6-6.8
52W High
-40%
52W Low
+20%
RSI
44
Rel Volume
0.19
Avg Volume
1.13K
Volume
220
Perf Week
0%
Perf Month
-2.7%
Perf Quarter
0%
Perf Half Y
-2.17%
-
-
-
-
Beta
0.234
-
-
Volatility
0.04%, 0.11%
Prev Close
0%
Price
3.6
Change
0.56%
Company Profile
- Volume Average 1.13K
- Market Capitalization 16.68M
- Employee 20
- CEO Mr. Stephane Ragusa
- Headquarters Villejuif,FR
- IPO Date 2018-12-21
-
Website
https://www.predilife.com 
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
